Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 2.050
+0.020 (0.99%)
Aug 15, 2025, 2:45 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 28.21 billion as of August 15, 2025. Its market cap has increased by 3.29% in one year.
Market Cap
28.21B
Enterprise Value
27.50B
Revenue
5.29B
Ranking
n/a
PE Ratio
2,936.15
Stock Price
2.05
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 28.21B, an increase of 994.07%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 28.21B | -13.04% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | 13.33B | -28.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.76B |
| WuXi AppTec | 286.17B |
| Shenzhen Mindray Bio-Medical Electronics | 286.01B |
| Aier Eye Hospital Group | 121.03B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
| Sichuan Biokin Pharmaceutical | 118.80B |
| Shanghai United Imaging Healthcare | 107.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |